CoChat

Discontinuing Psychiatric Medications: A Survey of Long-Term Users

Open access

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index; 5 of the 32 sources its claims cite were checked for support.

Abstract

OBJECTIVE: Individuals undergoing long-term psychiatric treatment frequently choose to stop taking psychiatric medications. To enhance service user choice and prevent undesirable outcomes, this first U.S. survey of a large sample of longer-term users sought to increase knowledge about users' experience of medication discontinuation. METHODS: A sample of 250 U.S. adults with a diagnosis of serious mental illness and a recent goal to stop up to two prescribed psychiatric medications, which they had taken for at least nine months, completed a web-based survey about experiences, strategies, and supports during discontinuation. RESULTS: About half (54%) met their goal of completely discontinuing one or more medications; 46% reported another outcome (use was reduced, use increased, or use stayed the same). Concerns about medications' effects (for example, long-term effects and side effects) prompted the decision to discontinue for 74% of respondents. They used various strategies to cope with withdrawal symptoms, which 54% rated as severe. Self-education and contact with friends and with others who had discontinued or reduced medications were most frequently cited as helpful. Although more than half rated the initial medication decision with prescribers as largely collaborative, only 45% rated prescribers as helpful during discontinuation. Of respondents who completely discontinued, 82% were satisfied with their decision. CONCLUSIONS: Discontinuing psychiatric medication appears to be a complicated and difficult process, although most respondents reported satisfaction with their decision. Future research should guide health care systems and providers to better support patient choice and self-determination regarding the use and discontinuation of psychiatric medication.

Overview

Integrity signals

Registry

Crossref · 10.1176/appi.ps.201700070

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

2 Valid · 3 Not valid · 15 Not checked · 51 Own results and interpretations

18 more claims

Create a free account to see all 71 claims and to verify the 27 references still open.

See all claims — free account
  • Probably not a substantial claim. 22
  • It may state two separate claims as one. 29
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 38 references

Research works printed but not linked: 3

  1. Stahl SM: Antipsychotics and Mood Stabilizers: Stahl's Essential Psychopharmacology. Cambridge, United Kingdom, Cambridge University Press, 2008
  2. Stahl SM: The Prescriber's Guide. Cambridge, United Kingdom, Cambridge University Press, 2011
  3. Improving the Quality of Health Care for Mental and Substance- Use Conditions: Quality Chasm Series. Washington, DC, National Academy of Sciences, 2006

Cited by

Metadata

Authors
Ostrow, L., Jessell, L., Hurd, M., Darrow, S. M., & Cohen, D.
Affiliations
University of California, Los Angeles (US)
Venue
Psychiatric Services
Published
2017-12-01
Volume
68
Issue
12
Pages
1232-1238
ISSN
  • 0022-1597 (ISSN-L)
  • 1075-2730
  • 1557-9700
OpenAlex
W2736261103
Cited by
62
References
38
Citations by year
2026: 4 · 2025: 8 · 2024: 7 · 2023: 6 · 2022: 4 · 2021: 12 · 2020: 6 · 2019: 9 · 2018: 5 · 2017: 1
FWCI
8.22
Type
journal article
Language
en
Open access
Locations
  • Psychiatric Services (publishedVersion)
  • PubMed (publishedVersion)
Funders
Foundation for Excellence in Mental Health Care
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
  • Health Sciences › Health Professions › General Health Professions › Mental Health and Patient Involvement
  • Social Sciences › Psychology › Clinical Psychology › Psychiatric care and mental health services
Keywords
severe mental illness, withdrawal symptoms, patient decision-making, patient satisfaction, self-determination, adverse drug reactions, self-education, peer support
MeSH terms
Adult, Mental Disorders, Female, Health Services Research, Humans, Male, Middle Aged, Patient Participation, Psychotropic Drugs, Substance Withdrawal Syndrome, Personal Autonomy, Medication Adherence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.